insurance dropping glp 1 As Insurers Drop GLP-1 Coverage, Advocates Search for a Hero in Obesity Employers Are Dropping GLP-1 Coverage
Description
It comes in the form of tirzepatide, a medication approved by the FDA in May 2022 to treat type 2 diabetes
Despite the significant burden of disease, effective pharmacological options remain limited, leaving lifestyle interventions based on dietary modification and physical activity as the mainstay of clinical management [6]
Most weight loss medications are FDA-approved for adults 18 years old and over for use in conjunction with behavioral modifications, diet and exercise
The efficacy of liraglutide on weight management was subsequently surpassed by semaglutide, which, when administered weekly at a dose of 2.4 mg in obese patients without diabetes, resulted in a weight reduction of 12.4% compared to placebo in the STEP 1 study [46], and a reduction of 9.4% compared to liraglutide 3.0 mg in the STEP-8 study [47]
Phentermine stimulates central nervous system catecholamine release to reduce appetite
It may be well to limit or avoid gastric stimulants such as caffeine, tea and alcohol.
